← FDA Drug Approvals (Drugs@FDA)
ABACAVIR SULFATE, LAMIVUDINE AND ZIDOVUDINE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MYLAN PHARMA · Approved 2009-07-15
Drug application
- FDA Application #
ANDA090309- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- ABACAVIR SULFATE, LAMIVUDINE AND ZIDOVUDINE
- Generic name
- Abacavir Sulfate
- Active ingredients
- ABACAVIR SULFATE; LAMIVUDINE; ZIDOVUDINE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- None (Tentative Approval)
- Sponsor
- MYLAN PHARMA
- First approval
- 2009-07-15
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown